These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35949313)

  • 1. Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration.
    Qin TT; Li ZH; Li LX; Du K; Yang JG; Zhang ZQ; Wu XX; Ma JL
    Iran J Basic Med Sci; 2022 Jun; 25(6):781-788. PubMed ID: 35949313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of Puerariae Lobatae Radix against lung cancer by inhibiting histone demethylase LSD1].
    Qin TT; Ma JL; Yuan Y; DU K; Miao JX; Li XF; Zeng HH; Wu XX; Li ZH
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5574-5583. PubMed ID: 36471975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing.
    Li Z; Qin T; Li Z; Zhao X; Zhang X; Zhao T; Yang N; Miao J; Ma J; Zhang Z
    Eur J Med Chem; 2021 Dec; 225():113778. PubMed ID: 34416665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
    Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
    J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells.
    Shan L; Li Z; Chen H; Ge M; Sun Y; Sun Y; Li Y; Li H; Fu L; Liu H
    Bioorg Chem; 2023 Feb; 131():106150. PubMed ID: 36508940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
    Ma Y; Zheng Y; Ji Y; Wang X; Ye B
    Future Med Chem; 2021 Mar; 13(6):533-542. PubMed ID: 33527838
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer.
    Li A; Ma T; Wang S; Guo Y; Song Q; Liu H; Yu B; Feng S
    Biomed Pharmacother; 2024 Apr; 173():116240. PubMed ID: 38401512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
    Li L; Li R; Wang Y
    Bioorg Med Chem Lett; 2019 Feb; 29(4):544-548. PubMed ID: 30611617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.
    Duan Y; Qin W; Suo F; Zhai X; Guan Y; Wang X; Zheng Y; Liu H
    Bioorg Med Chem; 2018 Dec; 26(23-24):6000-6014. PubMed ID: 30448189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors.
    Wang S; Li ZR; Suo FZ; Yuan XH; Yu B; Liu HM
    Eur J Med Chem; 2019 Apr; 167():388-401. PubMed ID: 30780087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
    Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
    Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sanguinarine targets BRD4 to suppress cell proliferation and migration in clear cell renal cell carcinoma.
    Wen Y; Song Y; Ma Y; Wen J; Yang J
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23451. PubMed ID: 37393519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.
    Xi J; Xu S; Zhang L; Bi X; Ren Y; Liu YC; Gu Y; Xu Y; Lan F; Zha X
    Bioorg Chem; 2018 Aug; 78():7-16. PubMed ID: 29524666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
    Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
    Vogt A; Tamewitz A; Skoko J; Sikorski RP; Giuliano KA; Lazo JS
    J Biol Chem; 2005 May; 280(19):19078-86. PubMed ID: 15753082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of vanadium complexes bearing tridentate schiff base ligands as novel LSD1 inhibitors.
    Lu LP; Liu JH; Cen SH; Jiang YL; Hu GQ
    Bioorg Med Chem Lett; 2019 Feb; 29(4):681-683. PubMed ID: 30611616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.
    Sun M; Liu C; Nadiminty N; Lou W; Zhu Y; Yang J; Evans CP; Zhou Q; Gao AC
    Prostate; 2012 Jan; 72(1):82-9. PubMed ID: 21538419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural compound library screening identifies Sanguinarine chloride for the treatment of SCLC by upregulating CDKN1A.
    Zhong M; Li X; Zhao F; Huang Y; Long Y; Chen K; Tian X; Liu M; Ma X
    Transl Oncol; 2022 Mar; 17():101345. PubMed ID: 35066462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells.
    Liu J; Zhu X; Yu L; Mao M
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):866-875. PubMed ID: 35350943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.